I3C increases BDNF expression, which promotes synaptic plasticity and neuronal survival, and the effects of I3C on the nervous system and cognition may be facilitated by this upregulation, thereby presenting treatment opportunities for diseases, such as PD, AD, and other neurodegenerative disorders. This evidence concerns the gene BDNF and Parkinson disease.